NCT05024214 2025-05-29Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors3D MedicinesPhase 1/2 Recruiting170 enrolled
NCT06498622 2024-07-12Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With EnvafolimabAnhui Provincial HospitalPhase 2 Recruiting45 enrolled